Medicares Maximum Fair Price negotiations for semaglutide, set to conclude in 2025, could reshape pricing dynamics nationwide
Molecular size limits : GLP-1 is a peptide hormone with a molecular weight of about 3,300 daltons
The new GLP-1 medications are very effective, and they have also made more people in medicine and outside of medicine aware of the harms that obesity can have
Possible reasons for the high rates of discontinuation include cost, variable efficacy, patient preferences, and/or GI adverse effects
[15] Patients should also seek immediate medical advice if they experience severe, persistent abdominal pain with or without vomiting (which could indicate pancreatitis), or right upper quadrant pain, fever, or jaundice (which could indicate gallbladder disease) both are important warnings in the FDA labeling for semaglutide products
No, it will not change because the headaches and other side effects are systematic